Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8226976 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 7 Pages |
Abstract
Our study suggests that high-dose extended-field radiotherapy alone is a curative therapy and shows favorable clinical outcome in patients with Stage I disease. With the high possibility of local control and primary failure of systemic dissemination, the integration of optimal radiotherapy with more effective systematic therapy is warranted to bring additional improvement to the outcome for these patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ye-Xiong M.D., Hua M.D., Jing M.D., Wei-Hu M.D., Qing-Feng M.D., Yong-Wen M.D., Zhao-Yang M.D., Shu-Nan M.D., Shu-Lian M.D., Yue-Ping M.D., Xin-Fan M.D., Zi-Hao M.D.,